Cambridge Investment Research Advisors, Inc. Conformis Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.56 - $0.83 $56 - $83
-100 Reduced 0.26%
38,100 $23,000
Q4 2021

Feb 03, 2022
BUY
$0.67 - $1.32 $2,462 - $4,851
3,675 Added 10.64%
38,200 $29,000
Q3 2021

Nov 02, 2021
BUY
$1.02 - $1.83 $4,080 - $7,320
4,000 Added 13.1%
34,525 $45,000
Q2 2021

Aug 10, 2021
BUY
$0.79 - $1.34 $24,114 - $40,903
30,525 New
30,525 $35,000

Others Institutions Holding CFMS

# of Institutions
2
Shares Held
5.79K
Call Options Held
0
Put Options Held
0
View Full List

About Conformis Inc

CFMS Quotes by TradingView
  • Ticker CFMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 187,856,992
  • Description
  • Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...
More about CFMS
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email